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Abstract
mvGST: Tools for Multivariate and Directional
Gene Set Testing
by
Dennis S Mecham, Master of Science
Utah State University, 2014
Major Professor: Dr. John R. Stevens
Department: Mathematics and Statistics
There are many platforms available for simultaneously measuring the relative activity,
or expression, levels of all genes in an organism. Genes that have systematically differ-
ent expression levels between experimental factor levels are called “differentially expressed”.
Because genes are annotated based on their known roles in biological processes (BP), molec-
ular functions (MF) and cellular components (CC), gene expression levels can be used to
determine relative activity levels of individual BP, MF, or CC between experimental fac-
tor levels (this is called gene set testing). Often multiple experimental differences are of
interest simultaneously, which necessitates multivariate gene set testing. Only genes that
contribute to a BP, MF, or CC are annotated to that gene set, and it is necessary to have
a consensus of genes contributing for a BP, MF, or CC to function properly. Because of
this, the direction of the differential expression (up of down regulated) matters. mvGST,
which is platform and design independent, includes tools to summarize and visualize results
from multivariate and directional gene set tests. This flexibility will be demonstrated on
two examples. The first example comes from a study evaluating the effect of different types
of fertilization on pig embryos at different stages in the embryos’ development. The second
example comes from a publicly available gene expression data set from a study evaluating
iv
the effect of different chemotherapy dosages on different leukemia blood cell lines. There
are plans to make mvGST available publicly through CRAN (Comprehensive R Archive
Network) or Bioconductor [1].
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1Chapter 1
Background
1.1 Motivating Example 1
An experiment was performed to better understand the differences in development
between different embryo types [2]. In the original study, there were 3 factors of interest:
cell type (C), embryo type (T), and gestation days (G). However, in this paper, only embryo
type and gestation days will be emphasized. Embryo type has 2 levels of most interest: in
vivo fertilization (IVV), and in vitro fertilization (IVF). Embryo type also has 2 more levels:
somatic cell nuclear transfer (“clone”), and parthenogenetic activation (“maternal clone”).
Gestation days has 3 levels: 10 days (when embryos have a spherical structure), 12 days
(when embryos have a tubular structure), and 14 days (when embryos have an elongated
filament structure). All of the samples being considered here come from the inner cell mass of
embryonic stem cells (ICM). This makes 12 combinations of embryo type and gestation days
that were sampled, but only 6 combinations that will be the main focus. The experimental
design is summarized in Table 1.1.
gestation days (G)
embryo type (T) 10 12 14
IVV 1 2 1
IVF 1 1 1
NT 1 2 1
PA 2 2 1
Table 1.1: Summary of design of motivating example 1. The number in each cell of the
table is the number of replicates for that combination.
To better understand the differences in embryo development, it is desired to determine
which biological processes were more, or less, active for each combination of embryo type
and gestation days. Because the level of activity of a biological process can be assessed by
2the relative activity, or expression, of the genes that contribute to that biological process,
it can be said that the objective of this experiment was to “identify and characterize genes
with expression differences between embryo types across gestation days.” [2] In addition
to determining which biological processes show expression differences, it is also desired to
classify those differences as either up-regulated or down-regulated.
1.1.1 Gene Expression Technology
There are a variety of technologies available for simultaneously measuring gene expres-
sion levels of all genes in an organism. In this example the RNA-Seq platform [3] was used.
The data produced for each sample contains the total number of RNA fragments detected
and the number of RNA fragments that map to each gene, thus allowing the expression level
of each gene to be measured relative to all other genes. Comparisons of gene expression
levels between factor levels (such as embryo types) can be done by having RNA-Seq data
on each sample.
1.1.2 Gene Sets
Extensive studies have been done to identify the functions of genes, or the roles genes
play in a given organism. Based on these results, genes can be grouped into sets of genes
with common roles. One of the most used representations of gene sets is Gene Ontology
(GO) [4]. GO has ontologies for biological processes (BP), molecular functions (MF), and
cellular components (CC). This example focused on BP. Each biological process has a gene
set that includes all genes that have been shown to contribute to the process, but none
that inhibit it. Basically, if the genes in the gene set are expressed, the biological process
proceeds. If any genes in the set are not expressed, the process may be “disturbed”. Even
as few as one gene in the set not being expressed may be enough to disturb the process [5].
Hill, et al [5] gives the example of the shh gene. When all products of the shh gene are
missing (the gene is not expressed at all), the process of heart development is “disturbed”.
This is just one example, but it shows the potential for the lack of a single gene’s expression
to have a negative effect on an entire biological process. For this reason, when testing gene
3sets for association with an experimental condition, it is important to test for a consensus
of significant differential expression between conditions rather than just test that at least
one of the genes in the set is significantly differentially expressed. If a gene set shows
consensus of differential expression, then the corresponding biological process can be said
to be differentially active between those conditions.
1.1.3 Statistical Methods Used in Analysis of Motivating Example
Because RNA-Seq data is in counts [3], Poisson regression was used in the motivating
example. A Poisson regression model was fit for each gene separately. The model used was
log(E[Yijkl]) = log(Nl) + µ+ Tj +Gk + TGjk (1.1)
where Nl is the total number of RNA fragments detected in replicate l, and Yijkl is the
fragment count for gene i in replicate l of gestation days (G) k, for embryo type (T) j. There
was no evidence of overdispersion that would make the Poisson model inappropriate [2].
1.1.4 Multivariate and Directional Differential Expression
In the motivating example, it is desired to compare in vivo fertilization versus in vitro
fertilization (IVV vs. IVF). This was done for each gene separately, as well as for each level
of gestation days. Contrasts were used to get each of the desired p-values for each gene
(Ho: IVV = IVF vs. Ha: IVV > IVF for each gestation day individually). There were 3
contrasts tested (IVV vs. IVF at 10/12/14 days) for each gene. The three contrasts for
each gene were
ψ(1) = T1 − T2 + TG11 − TG21 (1.2)
ψ(2) = T1 − T2 + TG12 − TG22 (1.3)
ψ(3) = T1 − T2 + TG13 − TG23 (1.4)
where the first two levels of embryo type (T) are IVV and IVF, respectively, and the
three levels of gestation days (G) are 10, 12, and 14 days, respectively. In all, 3 one-
4sided p-values were produced for each gene. As a result, there were 3 one-sided hypothesis
tests performed on each gene (and on each gene set), one test for each level of gestation
days. For the comparison of IVV vs. IVF, each gene set could be classified into a profile
based on the significance results (activity/expression levels for IVV are either significantly
greater than, significantly less than, or not significantly different than for IVF) at each
of the three gestation days (10, 12, 14). For example, a gene that is significantly less
expressed in IVV than IVF at day 10, but not significantly different at days 12 and 14,
would have the profile -1, 0, 0. This results in 3×3×3 = 27 different possible profiles in the
motivating example. This motivating example is just one case of how a test for differential
expression between conditions can be made at multiple levels of another factor. In this case,
differential expression between embryo types was tested at each level of gestation days. This
has been termed “multivariate differential expression” [2]. In general, there are 3n possible
profiles, where n is the number of levels in the factor across which the comparisons are made
(gestation days, in this case, because the comparison IVV vs. IVF was made for each level
of gestation days).
It seems worth emphasizing that the tests performed in this example, and in general,
by the R [6] package mvGST [7], which was developed for this MS report, will be one-sided
tests. This differs from other commonly used methods of gene set testing [8] [9] [10] [11]
that only attempt to find any differential expression of genes in the gene set, regardless of
direction.
The gene sets of GO only contain genes that contribute to a specific process, and
none that inhibit it [5]. Because of this, the results of a one-sided hypothesis test do
make sense. In this example, a one-sided test can determine if a specific biological process
is more active for IVV than IVF or vice versa, which is more informative than simply
determining that there is a some significant difference. In the case where some genes in the
corresponding gene set are significantly higher expressed in IVV and some are significantly
lower expressed in IVV, a one-sided test is not only more informative, but more meaningful.
In such a case, a two-sided test may conclude that the corresponding biological process is
5differentially expressed, but the lack of consensus does not provide evidence of differential
activity between IVV and IVF in either direction.
1.1.5 Desired Summary Format
The desired summary format from the multivariate gene set test in this motivating
example is a table showing the number of biological processes that fit into each profile for
IVV vs. IVF. It is also desired to be able to look at which biological processes fit each
profile.
1.2 Motivating Example 2
An experiment was performed to help understand how obatoclax mesylate, a drug
owned by GeminX Pharmaceuticals, treats leukemia [12]. A total of 12 samples were taken
from two leukemia cell lines, RS4:11 and SEM-K2 (six samples from each). Within each cell
line, three treatments were tested: control (CTL), low-dose obatoclax (LOW), and high-
dose obatoclax (HIGH). There were 2 samples for each combination of leukemia cell line
and treatment for a full 2× 3 factorial design with 2 replicates.
For demonstration purposes of the mvGST package, there are 2 objectives. The first
is to create profiles of all biological processes across all 4 combinations of cell lines and
LOW/HIGH vs. CTL. The second objective is to stratify the profiles by cell line. This
will create profiles for each of the 2 cell lines separately across the comparisons of LOW vs.
CTL and HIGH vs. CTL.
1.2.1 Gene Expression Technology
In this study, Affymetrix GeneChips [13] were used to collect gene expression data.
There are numerous statistical issues with the raw data, but they can be handled by RMA
preprocessing [14] [15] [16].
61.2.2 Linear Model
A linear model was fit for each gene using the limma package [17] in R. The model
accounted for leukemia cell line (L), treatment level (T), and their interaction. The model
used was
Yijkl = µ+ Tj + Lk + TLjk + ijkl (1.5)
where Yijkl is the log (base 2) of the expression level for gene i in replicate l of treatment
level (T) k, for leukemia cell line (L) j. ijkl follows a normal distribution with variance σ
2.
Four contrasts were tested (HIGH/LOW vs CTL at each cell line) withHo: HIGH/LOW
= CTL vs. Ha: HIGH/LOW > CTL. The four contrasts tested for each gene were
ψ = T1 − T3 + TL11 − TL31 (1.6)
ψ = T1 − T3 + TL12 − TL32 (1.7)
ψ = T2 − T3 + TL21 − TL31 (1.8)
ψ = T2 − T3 + TL22 − TL32 (1.9)
where the levels of treatment (T) are high doses of obatoclax, low doses of obatoclax, and
control, respectively, and the two levels of leukemia cell line (L) are RS4:11 and SEM-K2,
respectively.
1.3 P-value Combination
The contrasts in Sections 1.1.4 and 1.2.2 provide p-values for the differential expression
of each gene individually. In order to make a conclusion about the differential activity of
each biological process it is desired to have one p-value per contrast for each gene set being
tested. There are many ways to do this. Fisher’s p-value combination method [18] and
Goeman’s [8] global test have been shown to be powerful [19]. However, Goeman’s global
test is only for testing association of a gene set with a single “clinical outcome”, which makes
it unsuitable for multivariate differential expression. Fisher’s method uses individual genes’
7p-values (as can be calculated for each contrast) and then combines them into a single
p-value for the gene set. Both of these methods essentially test Ho: “none of the genes
are differentially expressed” vs. Ha: “at least one of the genes is differentially expressed”.
As discussed previously in Sections 1.1.2 and 1.1.4, however, a more meaningful null and
alternative would be more appropriate.
1.3.1 Fisher’s Method
The test statistic in Fisher’s method is
∑n
i=1−2log(pi), which follows a χ22n distribution
under Ho, where n is the number of p-values being combined and pi is the i
th p-value. The
combined p-value is the tail probability [18].
The null hypothesis for Fisher’s method is the same as the individual null hypotheses
for the p-values being combined (which implies that the original hypotheses tested must all
be the same). The alternative hypothesis is that at least one of the common alternatives
tested is true. In gene set testing, this means that at least one of the genes is differentially
expressed. However, this may not be enough for the gene set, as a whole, to have any
significant change in biological process activity. As discussed in section Section 1.1.2, the
lack of just one gene being expressed can“disturb”a biological process, which means a single
significantly differentially expressed gene may not be enough to overcome the genes that
are not differentially expressed. It is more meaningful to use an alternative hypothesis that
indicates “collective support” [20].
1.3.2 Stouffer’s Method
Stouffer’s method [21] was shown by Fridley [19] to be nearly as powerful as Fisher’s
method for gene set testing. However, Stouffer’s method tests for consensus and has been
shown to be superior to Fisher’s method in cases where consensus is more suitable [22],
which is the case for gene set testing (as discussed in Section 1.1.2).
Stouffer’s method calculates a combined z-statistic that follows a standard normal
distribution. This test statistic is Z =
∑n
i=1(Φ
−1(pi))/
√
n where n is the number of p-
values being combined, pi is the i
th p-value, and Φ is the cumulative density function of the
8standard normal distribution. The combined p-value is the upper tail probability [21].
1.3.3 Stouffer’s vs Fisher’s
Although Fisher’s method is more powerful, Stouffer’s method has a more useful alter-
native hypothesis for gene set testing and has the benefit of symmetry.
1.3.3.1 Alternative Hypotheses
As discussed in Sections 1.3.1 and 1.3.2, Fisher’s method is unsuitable for combining
p-values in gene sets because the alternative for Fisher’s method is that at least one of
the genes is differentially expressed, which may or may not actually be enough to make
a difference for the entire gene set (and, consequently, the activity of the corresponding
biological process). Stouffer’s method tests for a consensus of activity, which is generally a
more meaningful alternative for gene set testing.
1.3.3.2 Symmetry
Because all of the p-values being combined are one-sided p-values, it is important that
significantly high p-values and significantly low p-values are given equal weight. This is
what symmetry means in this case. Stouffer’s method has symmetry. Fisher’s method,
however, gives more weight to p-values near 0 than p-values near 1.
One reason symmetry is important is because the direction of the alternative hypothesis
is completely arbitrary. If p is the one-sided combined p-value for a gene set under the
alternative hypothesis X > Y , where X and Y are activity levels under two different
treatments, then 1− p should be the combined p-value for the alternative hypothesis X <
Y . If this is true, then the arbitrary decision of which way the inequality points in the
alternative hypothesis has no bearing on the results. This is true for Stouffer’s method, but
not for Fisher’s method. A simple example can demonstrate this. Suppose the alternative
hypothesis tested is X > Y and 2 genes that make up a gene set have the p-values 0.01 and
0.3. With a significance threshold α = 0.05, a combined p-value of less than 0.025 or greater
than 0.975 is considered significant. For this gene set, Stouffer’s method yields a significant
9result (p = 0.0219), as does Fisher’s method (p = 0.0204). Now suppose the alternative
hypothesis is flipped to be X < Y , so the gene’s p-values are 0.99 and 0.7, respectively.
Notice that the magnitude (or absolute difference from 0.5) of the p-values hasn’t changed;
the new p-values are equal to one minus the original p-values. Now Stouffer’s method
gives a significant result (p = 0.9781), but Fisher’s method gives a non-significant result
(p = 0.9471). Also notice that the new Stouffer’s p-value, 0.9781, is equal to one minus the
original Stouffer’s p-value, 0.0219 (i.e., Stouffer’s method is symmetric). Fisher’s method,
however, is not symmetric (0.9471 6= 1 − 0.0204). In this example, the arbitrary choice of
alternative hypothesis determined whether or not Fisher’s method gave a significant result.
Another reason symmetry is so important, is because some gene sets have bimodal
distributions of p-values. Stevens and Isom showed that this may be very common [2].
Because of the lack of symmetry, Fisher’s method may give nonsense conclusions for these
bimodal gene sets. Assume Ho : X = Y vs. Ha : X < Y are the hypotheses being tested
here. One possibility is a gene set is split down the middle with about half of the p-values
near 1 (indicating, for example, X > Y ) and about half near 0 (X < Y ). In this scenario, a
Stouffer’s combined p-value near 0.5 makes sense (due to the lack of consensus), but Fisher’s
method may give a significant result (the Fisher’s combined p-value would be near 0 because
“at least one” of the genes in the set was differentially expressed). Suppose a gene set with 2
genes has the p-values 0.01 and 0.99. Both genes are significant, but in opposite directions
(i.e., there is a lack of consensus), which should result in a non-significant combined p-value.
Stouffer’s method gives a combined p-value of 0.5, but Fisher’s method gives a p-value of
0.0079 (concluding that at least one of the genes is differentially expressed).
Another possibility is that a gene set has a Stouffer’s consensus p-value near 1, but a
small number of p-values near 0. It is possible that Fisher’s method will actually give a
significant result (small p-value) in favor of the small group of p-values near 0. Suppose a
gene set with 4 genes has the p-values 0.9990, 0.9900, 0.9900, 0.0001. In this case, Stouffer’s
method gives a combined p-value of 0.9779 (significant consensus that X > Y , but Fisher’s
method gives a p-value of 0.0180 (concluding that at least one gene has X < Y ) even though
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there was only one gene that didn’t have a p-value near 1.
1.4 Multiple Hypothesis Testing
In both motivating examples, and in any other similar study, many hypothesis tests are
being performed. There are multiple tests done on thousands of gene sets. If no adjustment
for multiple hypothesis tests is made, then there will be numerous type I errors made. For
example, with 20,000 p-values (perhaps 4 tests performed on 5,000 gene sets) there will be
approximately 1000 type I errors made if the per-comparison type I error rate is controlled
at 0.05.
One approach is to control the familywise type I error rates (FWER) with methods
such as Holm’s [23]. These methods assure that the probability of at least 1 type I error is
less than or equal to a predetermined α. However, they tend to be overly conservative [24].
Another approach, first proposed by Yoav Benjamini and Yosef Hochberg, is to control
the false discovery rate (FDR) [24]. The FDR is defined as the expected proportion of type
I errors to the number of rejected null hypotheses. Because controlling the FDR allows for
some type I errors, it is a more powerful approach than controlling the familywise type I
error rate. Controlling the FDR is more suitable for exploratory studies, where it is not
essential that there are no type I errors, and increased power is desired. Controlling the
FWER is preferred more for confirmatory studies.
The approach originally proposed by Benjamini and Hochberg, however, assumes that
the p-values are independent. Benjamini and Daniel Yekutieli showed that this procedure
also controls the FDR for some dependency structure among the p-values [25], but the
dependency structure among p-values of gene sets is completely unknown [26]. P-values
from parent and child gene sets must be dependent since all of the genes in a child set are
also in the parent set [4]. Therefore, it is necessary to use a method that will control the
FDR regardless of dependent p-values. The method proposed by Benjamini and Yekutieli
achieves this [25].
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1.5 Potential for Generalization
It is becoming increasingly common for experiments to test multiple hypotheses for
each gene, rather than a single comparison [2], which is not what existing gene set testing
methods are designed to do. Existing methods like globaltest [8] and ROAST [11] identify
gene sets that are associated with a single comparison. Although the method of performing
those hypothesis tests depends on the form of the data (e.g., contrasts in a Poisson model
for example 1, or contrasts in a linear model for example 2), mvGST takes the p-values for
all hypotheses tested on each gene and characterizes the significance, or lack thereof, of each
gene set for the tests performed. Because mvGST takes p-values as input, it can be used
with any platform for obtaining gene expression levels. mvGST also offers the advantage of
performing meaningful one-sided tests, which differs from existing methods.
1.5.1 Translating Gene Names to GO
Each platform for collecting gene expression data has its own gene naming system. GO
is not platform specific, but the gene names do need to be translated to GO. A couple of
gene naming systems (Affymetrix, Entrez) can easily be translated to GO with tools from
the package topGO [27] in R. However, there are many more systems in use that do not
easily convert with current tools. There is an R package that is capable of making the
conversion, gProfileR [28], but going directly to GO in this package takes far too much time
to ever be practical. Testing showed that each extra gene name that is translated to GO
adds anywhere from a couple seconds to several minutes to the overall time (presumably
depending on how many gene sets the gene is a part of). This increase in time appears to
be a linear increase. Instead, this packages is used to translate other gene naming systems
to Entrez ID’s which can then be easily translated to GO.
1.5.1.1 Many to One, One to Many
This translation isn’t always one-to-one, however. Suppose the original gene naming
system used in a study is called xyz. Undoubtedly, xyz and Entrez ID’s would not be a
perfect match. Some genes in xyz would translate to 2 or more genes in Entrez. Some
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groups of 2 or more genes in xyz would translate to a single gene in Entrez. This problem
may be avoided by using either Entrez or Affymetrix ID’s originally, since they can easily
be mapped to GO, but some researchers may not have data in that form. For a researcher
with data from a different naming system, the only way to avoid the translation issues is
to provide their own list of gene sets, but this may not be practical. This mvGST package
provides several potential solutions that will be discussed in Sections 2.1.1.1, 2.1.1.2, 2.1.1.3,
and 2.1.1.4. Admittedly, all of the solutions have drawbacks and the choice of what solution
to use is left to the user.
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Chapter 2
Methods
There are 4 main functions in the package mvGST : profileTable, pickOut, graphCell,
and go2Profile. After profileTable has been run, the other 3 main functions can be used on
the result. Sections 2.1, 2.2, 2.3, 2.4 and 2.5 summarize these functions and their arguments.
Then the functions are demonstrated on both examples from Chapter 1.
2.1 profileTable
profileTable achieves the main goal of the package and sets up the use of the other 3 main
functions. profileTable takes a matrix (rows representing genes and columns representing
contrasts) of one-sided p-values, a vector of gene names (in order so that the gene names
correspond to the rows of the matrix of p-values), and a vector of contrasts tested (in order
so that the contrasts correspond to the columns of the matrix of p-values; format will be
discussed in Section 2.2.1) and produces an object of class mvGST with a matrix showing
the number of gene sets that fit each significance profile for each stratum, if any. Strata used
are determined by the vector of contrasts and will be discussed in Section 2.2.1. An mvGST
object is a list that also contains other information which will be outlined in Section 2.2.2.
The first thing profileTable looks at is whether or not the user has provided a list of gene
sets (which would be useful if the user want to avoid potential problems caused by translating
to Entrez before mapping to GO (see Section 1.5.1.1). If not, then a list is generated that
maps the genes to GO. The list generated depends on the type of gene names provided, as
well as the desired ontology: biological processes (BP), molecular functions (MF), or cellular
components (CC). If the gene names are Affymetrix, Entrez, Genbank, Alias, Ensemble,
Symbol, Genename, or Unigene ID’s, then functions from the package topGO [27] are used to
generate the list. These functions do not provide a complete mapping (genes that are already
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mapped to a child set are not mapped to the parent set), so the appropriate OFFSPRING
object from the package GO.db [29] is used to complete the list of gene sets. For example, if
BP is selected, then GOBPOFFSPRING is used to complete the list generated from topGO.
If the gene naming system is anything else, then the function gconvert from the gProfileR
package is used to translate the gene names to Entrez. Then the gene set list is generated
in the same way as before. If the gene names do have to be translated, then there will
be issues with one-to-many and many-to-one (see Section 1.5.1.1) translation. There are 4
methods available to handle these issues in the mvGST package.
2.1.1 Note on Gene Name Translation Methods
Based on the available literature, there does not seem to be a commonly used way
of handling the issues (see Section 1.5.1.1) that arise in translating gene names from one
naming system to another. The methods described in the following sections do not attempt
to be definitive solutions, rather they are just a few possible ways of handling the problem.
How valuable these options are varies from case to case (some translations may have very
few issues, others may have many). How big of a problem it is to ignore the issue altogether
may also depend on what the minimum size gene set included in the analysis is (a smaller
gene set would be more affected by a duplicate p-value). Without further research, it is very
difficult to know how often the translation issues have a significant effect on the analysis.
2.1.1.1 Method 1
The first method is to ignore the problem all together. This will cause problems, but
those problems may not be bad enough to justify any action.
If one gene name translates to many, then all of those genes will have the same p-values
and, certainly, will be in many of the same gene sets. This will cause a problem when the p-
values in each set are combined using Stouffer’s method because Stouffer’s method assumes
independent p-values. If the sets being tested are small, then having two or more p-values
that are completely dependent is a big problem. However, if the gene sets being tested are
large, then maybe it’s not much of a problem. It is up to the user to decide what constitutes
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a big problem.
When many gene names are translated to just one gene name, there are similar prob-
lems. This will result in multiple rows of p-values for the same gene. Most likely, the
multiple p-values for that gene will be very dependent, since Entrez considers them to be
from the same gene. This will cause problems with the Stouffer combination method used
within each gene set. Once again, the user must determine if this is a big problem or not.
Table 2.1 shows an example of 4 Affymetrix ID’s that were translated to Entrez ID’s.
One of the Affymetrix ID’s translates to two Entrez ID’s, and two of the Affymetrix ID’s
translate to the same Entrez ID. After applying method 1, Entrez ID’s 780 and 100616237
have the same p-value because they were translated from the same Affymetrix ID, and
Entrez ID 5594 has two p-values because it was translated from two different Affymetrix
ID’s.
Affymetrix ID Entrez ID P-value
1007_S_AT 780 and 100616237 0.5045
1053_AT 5982 0.4665
1552263_AT 5594 0.3436
1552264_A_AT 5594 0.3506
After applying method 1
1007_S_AT 780 0.5045
1007_S_AT 100616237 0.5045
1053_AT 5982 0.4665
1552263_AT 5594 0.3436
1552264_A_AT 5594 0.3506
Table 2.1: Example of method 1 used on Affymetrix ID’s that are translated to Entrez ID’s
2.1.1.2 Method 2
The second method ignores the one-to-many problem, but provides a solution for the
many-to-one problem. When many gene names are translated into just one gene names,
that one gene has multiple p-values for each contrast and would be included multiple times
in every gene set that includes it. Method 2 combines those multiple p-values into one for
each contrast so that the new p-value matrix has just one row for that gene like it should
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have. Method 2 uses Stouffer’s method [21] to combine the p-values.
Table 2.2 uses the same genes and p-values as in Table 2.1 to demonstrate method 2.
The only difference is that Entrez ID 5594 is now only included once in the results with
a p-value that is the Stouffer combination of 0.3436 and 0.3506. The internal functions
of profileTable also treat the Affymetrix ID as if it were “other 1”, but that only makes a
difference if method 4 is used (Section 2.1.1.4).
Affymetrix ID Entrez ID P-value
1007_S_AT 780 and 100616237 0.5045
1053_AT 5982 0.4665
1552263_AT 5594 0.3436
1552264_A_AT 5594 0.3506
After applying method 2
1007_S_AT 780 0.5045
1007_S_AT 100616237 0.5045
1053_AT 5982 0.4665
other 1 5594 0.2891
Table 2.2: Example of method 2 used on Affymetrix ID’s that are translated to Entrez ID’s
2.1.1.3 Method 3
The third method provides a solution for the one-to-many problem, but ignores the
many-to-one problem. When one gene name is translated to many gene names, the p-values
for that one gene are duplicated and, essentially, extra data is created. Usually, more data
is a good thing, but not when it is fabricated in this way. Those genes are also likely to be in
many of the same gene sets, which will violate the assumption of independence in Stouffer’s
method. To treat this problem, the many genes must be converted back into one, and the
only way to do that is to just pick one. For that reason, method 3 treats the one-to-many
problem by simply eliminating all but the first of the “many”. Using this method, any gene
that would be translated to many genes, instead is translated to the first gene that gconvert
associates it with. Although this does provide a solution to the one-to-many problem, such
an arbitrary solution may not be desirable.
Table 2.3 uses the same genes and p-values as in Table 2.1 to demonstrate method 3.
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The only difference from method 1 is that Entrez ID 100616237 is no longer included in the
results.
Affymetrix ID Entrez ID P-value
1007_S_AT 780 and 100616237 0.5045
1053_AT 5982 0.4665
1552263_AT 5594 0.3436
1552264_A_AT 5594 0.3506
After applying method 3
1007_S_AT 780 0.5045
1053_AT 5982 0.4665
1552263_AT 5594 0.3436
1552264_A_AT 5594 0.3506
Table 2.3: Example of method 3 used on Affymetrix ID’s that are translated to Entrez ID’s
2.1.1.4 Method 4
The fourth method is merely a combination of the second and third methods. Method
4 first runs method 2, and then a modified version of method 3 that ensures that any rows
with Stouffer combined p-values will not be eliminated by mistake.
Table 2.4 uses the same genes and p-values as in Table 2.1 to demonstrate method 4.
Notice that the p-values for Entrez ID 5594 were combined into one p-value, just like in
method 2, and Entrez ID 100616237 has been eliminated, just like in method 3.
Affymetrix ID Entrez ID P-value
1007_S_AT 780 and 100616237 0.5045
1053_AT 5982 0.4665
1552263_AT 5594 0.3436
1552264_A_AT 5594 0.3506
After applying method 4
1007_S_AT 780 0.5045
1053_AT 5982 0.4665
other 1 5594 0.2891
Table 2.4: Example of method 4 used on Affymetrix ID’s that are translated to Entrez ID’s
18
2.1.2 Limitations
There are a couple of situations that are not adequately accounted for in these meth-
ods. For example, suppose gene names A and B were translated to gene names α, β and γ
as shown in Table 2.5. Running method 4 would first use Stouffer’s method to combine the
p-values associated with β. The combined p-value would be associated with the original
name “other 1” as shown in Table 2.6. Notice that the one-to-many problem that existed
in Table 2.5 is gone. Thus, when method 4 is complete, there will be 3 rows of p-values
even though there were only 2 originally (for A and B). Method 4 is supposed to avoid this
fabrication of extra p-values. In testing, this problem seems rare.
Original Names Translated Names Type of P-value P-value
A α raw 0.1
A β raw 0.1
B β raw 0.9
B γ raw 0.9
Table 2.5: Hypothetical gene name translation with many-to-one and one-to-many problems
Original Names Translated Names Type of P-value P-value
A α raw 0.1
other 1 β Stouffer 0.5
B γ raw 0.9
Table 2.6: Hypothetical gene name translation after running method 4
2.2 profileTable continued
Once there is a list of gene sets, an object of class mvGST is created with all of the
essential information that needs to be passed through the internal functions.
First, the rows of the provided matrix of p-values are grouped according to gene sets.
Within each group, p-values are combined using Stouffer’s method. The results are a matrix
of p-values with each row representing a gene set and each column representing a contrast.
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Second, the FDR is controlled with a Benjamini-Yekutieli adjustment [25] within each
contrast (column of the p-value matrix). If the FDR is controlled within each column, then
it is controlled overall [30].
Next, the matrix of adjusted p-values is converted to a matrix of ones, zeroes, and
negative ones representing significance. The p-values are compared to thresholds α/2 and
1 − α/2. Because the p-values should be one-sided and come from tests of the form H0 :
µ1 = µ2 vs H1 : µ1 > µ2, p-values that are less than α/2 are converted to 1 (significantly
greater than), and p-values that are greater than 1− α/2 are converted to -1 (significantly
less than). All other p-values are converted to 0.
Finally, a table is created showing how many gene sets fit each profile for each stratum,
or just how many gene sets fit each profile overall. The possible profiles and the strata, if
any, that are displayed in the table are determined by the contrasts argument. The contrasts
must be in either the format: Var1.Var2, or in the format: Var1 (in other words, Var2 is
optional). The number of unique levels of Var1 determines the number of dimensions of
the profiles. The number of levels of Var2 determines the number of strata. After the table
is created, all 0 rows are removed and the rows are sorted so that the rows with the most
gene sets come first.
2.2.1 profileTable Arguments
profileTable has the following 12 arguments:
 gene.names
gene.names must be a character vector containing the gene names that correspond to
the rows of the matrix of p-values.
 contrasts
contrasts must be a character vector containing the contrasts that correspond to each
column in the matrix of p-values. It must either be in the format: Var1 or Var1.Var2
(Var2 is optional). The number of levels in Var1 determines the dimensions of the
profiles (e.g., if Var1 has 2 levels, then there will be two columns for the profiles in
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the returned table). Var2 determines the number of columns, or strata, that will be
reported in the returned table for each profile. If Var2 is not given, then there will
only be one column reported, which will be the ontology chosen.
 pvals
pvals must be a matrix containing one-sided p-values corresponding to the various
genes (rows) and contrasts (columns). It is assumed that the one-sided p-values result
from per-gene tests of the form Ho : ψ = 0 vs. Ha : ψ > 0 for each contrast ψ (so
small p-values suggest ψ > 0, and large p-values suggest ψ < 0).
 list.groups
list.groups is an optional list containing user-defined gene sets. The names of the list
are the names of the gene sets. Each element of the list is a character vector containing
the gene names in each gene set.
 sig.level
sig.level is the α level that should be used. The default is 0.05.
 gene.ID
gene.ID is the gene naming system used for the gene names. It is used to generate
a list of gene sets mapping genes to Gene Ontology sets. For Entrez ID’s, gene.ID
should be ”Entrez”. For Affymetrix ID’s, gene.ID should be ”affy”.
 organism
organism is the organism that the genes come from. It is used to generate a list of gene
sets mapping genes to Gene Ontology sets. organism should be in the form of the first
letter of the scientific name followed by the second word of the scientific name with no
space in between. For example, human is “hsapiens”. All allowed values are: “agam-
biae”, “athaliana”, “btaurus”, “celegans”, “cfamiliaris”, “dmelanogaster”, “drerio”, “eco-
liK12”, “ecoliSakai”, “ggallus”, ”hsapiens”, ”mmusculus”, ”mmulatta”, ”pfalciparum”,
”ptrogldytes”, “rnorvegicus”, “scerevisiae”, “scoelicolor”, “sscrofa”, ”tgondii”, and ”xlae-
vis”.
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 affy.chip
affy.chip is the type of Affymetrix gene chip used, if gene.ID is ”affy”.
 ontology
ontology is the ontology that should be used for generating gene sets: ”BP”, ”MF”, or
”CC”.
 method
method is the method for handling gene name translation issues. It can be set to either
1, 2, 3 or 4, corresponding to Sections 2.1.1.1, 2.1.1.2, 2.1.1.3, 2.1.1.4, respectively.
 minsize
minsize is the minimum size gene set that will be included in the generated list [31].
 maxsize
maxsize is the maximum size gene set that will be included in the generated list [31].
2.2.2 profileTable Returns
profileTable returns an object of class mvGST. An object of class mvGST is a list
containing the following components:
 results.table
This is the primary result. It is a matrix with possible profiles as row names and
contrasts as column names. The cells of the matrix show how many gene sets have
each profile for each contrast.
 raw.pvals
raw.pvals is a matrix of the original p-values provided with gene names as row names
and contrasts as column names.
 grouped.raw
grouped.raw is a matrix of Stouffer combined p-values. Each row is for a gene set and
each column is for a contrast.
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 adjusted.group.pvals
adjusted.group.pvals is the same matrix as in grouped.raw, but with a Benjamini-
Yekutieli (BY) adjustment being performed within each column.
 ones.zeroes
ones.zeroes is a matrix showing the significance results of each of the BY adjusted
p-values. 1 means significantly greater. -1 mean significantly less. 0 means not
significant.
 ord.lev
ord.lev contains the levels of Var1 (see Section 2.2.1).
 contrasts
contrasts contains the strata that are the column names of results.table. These are
the levels of Var2 (see Section 2.2.1).
 group.names
group.names contains the names of the gene sets, whether they were provided or
generated.
2.3 pickOut
pickOut uses the resulting table from profileTable, and allows the users to see which
gene sets contribute to the totals in each cell of the table. The user specifies a row and
column of the table, and pickOut returns the ID’s of the gene sets that have the profile of
the specified row for the strata of the specified column.
2.3.1 pickOut Arguments
pickOut has the following 3 arguments:
 mvgst
mvgst is a mvGST object with a final results.table, as returned by profileTable.
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 row
row is the row number of the desired profile in the table returned by profileTable.
 col
col is the column number of the desire stratum. Column refers to the levels of Var2
(Section 2.2.1), if Var2 was used. It is the number of the column after the 1, 0, -1
columns that show the profiles. Default value is 1.
2.3.2 pickOut Returns
The pickOut function returns a character vector containing the ID’s of the gene sets in
the specified row and column.
2.4 graphCell
The graphCell function visualizes the gene sets exhibiting a particular profile. For
graphCell to be used, the gene sets must have GO ID’s, which will always be the case if the
user does not provide their own list of gene sets. graphCell is similar to pickOut, except,
instead of just returning the ID’s, graphCell creates a GO graph of the selected gene sets.
This gives the user a visual representation of how those gene sets are related. graphCell
makes use of tools from the package Rgraphviz [32] to make the GO graph interactive.
Within the GO graph, the nodes of the selected cell (i.e., the GO terms classified to the
selected profile) are colored yellow.
2.4.1 graphCell Arguments
graphCell has the following 7 arguments:
 object
object is a mvGST object with a final results.table, as returned by profileTable.
 row
row is the row number of the desired profile in the table returned by profileTable.
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 col
col is the column number of the desired stratum. Column refers to the levels of Var2
(Section 2.2.1), if Var2 was used. It is the number of the column after the 1, 0, -1
columns that show the profiles. Default value is 1.
 ontology
ontology is the ontology, within Gene Ontology, that should be used (“BP”, “MF”,
“CC”).
 interact
interact indicates whether or not the graph should be interactive. Clicking on the
interactive graph will display a legend with the GO ID and name of the gene set
represented by the node closest to the point of the click. If interactive is TRUE, the
escape button ends interaction with the graph.
 legend.pos
If interactive is TRUE, legend.pos indicates the desired position of the legend that
shows name and GO ID of selected node. Allowable values are “bottomright”, “bot-
tom”, “bottomleft”, “left”, “topleft”, “top”, “topright”, “right”, and “center”.
 print.legend
print.legend indicates if a legend should also be printed separately, showing GO names
of all nodes. It is impossible to fit GO names, or even just GO ID’s, into nodes of the
graph. Instead, the nodes are numbered and the legend shows which number matches
which GO name.
2.5 go2Profile
go2profile allows a user to see which profile one or more gene sets fit for each strata.
The result is a table, or list of tables, that are similar to the table from profileTable except
that only one gene set is included.
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2.5.1 go2Profile Arguments
go2Profile has the following 2 arguments:
 names
names is a character vector with the names, or ID’s, of the gene sets of interest. If
the gene set names were not provided by the user, then this should be the GO ID’s
of the gene sets of interest.
 object
object is a mvGST object with a final results.table, as returned by profileTable.
2.5.2 go2Profile Returns
A list of matrices is returned by go2Profile. Each matrix has possible profiles as the row
names and strata as the column names. Ones in the appropriate cells show which profile
the gene set fits for each strata and zeroes elsewhere. The names of the list are the names,
or ID’s, provided.
2.6 Demonstration of Package
2.6.1 Motivating Example 1
In the first motivating example, in vivo fertilization (IVV) is compared to in vitro fertil-
ization (IVF) at gestation days (G) 10, 12, and 14. In the example code below, gene.names1
is a character vector containing the gene names, which are Entrez ID’s. Also in the code
below, the vector contrasts1 contains:
[1] "G10.IVV.IVF" "G12.IVV.IVF" "G14.IVV.IVF"
Notice that profileTable interprets this as being in the form Var1.Var2 with the first
period being the divider. Also in the code below, pvals1 is a matrix of one-sided p-values
with rows representing genes and columns representing contrasts. The first 6 rows are
displayed below:
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[,1] [,2] [,3]
[1,] 0.000000e+00 1.000000e+00 6.470000e-211
[2,] 0.000000e+00 9.720000e-127 1.078557e-03
[3,] 4.880000e-32 1.000000e+00 1.000000e+00
[4,] 1.867933e-01 5.249269e-01 1.000000e+00
[5,] 1.580000e-68 1.000000e+00 8.289168e-01
[6,] 9.999632e-01 1.539993e-01 9.914408e-01
Even though the samples in this study came from pigs, due to the custom nature of
the experimental lab’s gene-naming database, it was necessary to translate the gene names
to homologous human genes. For that reason, the organism is human. Since the scientific
name for human is homo sapiens, the organism needs to be “hsapiens”. The ontology is set
to “BP” because only biological processes are of interest. Since only gene sets with between
5 and 1000 gene were considered, minsize equals 5 and maxsize equals 1000. Thus, the
appropriate function call is:
> example1 <- profileTable(gene.names1, contrasts1, pvals1,
+ gene.ID ="Entrez", organism = "hsapiens",
+ ontology = "BP", minsize = 5, maxsize = 1000)
Table 2.7 shows the output from profileTable. The output shows that 5510 gene sets
(biological processes) with between 5 and 1000 genes show no significant activity difference
between IVV and IVF at any of the days tested. Also, using row 9 as an example, 2 gene
sets have the profile that they are significantly more active in IVV than IVF at gestation
days 10 and 12, but significantly less active at day 14. Suppose that this profile (1, 1, -1)
is of particular interest. To see which 2 gene sets fit that profile, pickOut can be used. In
this case, the output from profileTable was saved as example1. The profile of interest is in
the 9th row. There is only one stratum that was tested, so the column of interest is 1. The
correct function call is:
> gene.sets <- pickOut(example1, 9, 1)
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G10 G12 G14 IVV.IVF
0 0 0 5510
0 0 1 730
-1 0 1 243
-1 0 0 115
1 0 0 24
0 1 0 22
0 -1 0 17
0 0 -1 15
1 1 -1 2
1 1 0 2
-1 -1 0 1
-1 1 -1 1
1 0 -1 1
Table 2.7: output from profileTable for first example:
[1] "GO:0045916" "GO:2000258"
This gives the GO ID’s of the 2 gene sets that fit the profile of interest. It is also
possible to make a GO graph of these 2 sets (and all of their parent nodes) using graphCell.
The way graphCell is called is very similar to pickOut :
> graphCell(example1, 9, 1, interact = FALSE, print.legend = FALSE)
The only difference, in this case, is that interact and print.legend are both set to FALSE
for convenience. Figure 2.1 shows the desired graph. The 2 yellow nodes are the 2 gene sets
that fit the profile of interest.
Lastly, suppose the gene set GO:0045916 is of particular interest. The function go2Profile
can be used by just providing the gene set ID and the original profileTable output:
> profile <- go2Profile("GO:0045916", example1)
This output (Table 2.8) says that for the IVV.IVF contrast, GO:0045916 had a profile of
(1, 1, -1) across the gestation days 10, 12, and 14.
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Fig. 2.1: GO graph showing GO:0045916 (node 1) and GO:2000258 (node 2) within the
framework of all parent GO BP terms
2.6.2 Motivating Example 2a
In the second motivating example, high and low doses of obatoclax are given to both
of the RS4:11 and SEM-K2 cell lines. These dosed groups can be compared to a control
group within each cell line. In the code below, the object gene.names2 is a character vector
containing the gene names, which are Affymetrix ID’s. The type of Affymetrix gene chip
used is hgu133plus2. In the code below, the object contrasts2a contains:
[1] "RS4Low" "RS4High" "SEMK2Low" "SEMK2High"
Notice that profileTable interprets this as being in the form Var1 because there are no
periods in the names. Also in the code below, pvals2 is a matrix of one-sided p-values with
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$`GO:0045916`
G10 G12 G14 IVV.IVF
1 1 -1 1
Table 2.8: Table showing profile of the gene set GO:0045916
rows corresponding to genes and columns corresponding to contrasts. The first 6 rows of
pvals2 are:
[,1] [,2] [,3] [,4]
[1,] 0.5044534 0.2717903 0.5389786 0.68724607
[2,] 0.4665344 0.3121148 0.1162036 0.53931978
[3,] 0.8135495 0.7929617 0.9584846 0.65778015
[4,] 0.3793150 0.1299377 0.5644299 0.38994582
[5,] 0.1318970 0.2182358 0.5302079 0.30793280
[6,] 0.1416885 0.5124254 0.4539475 0.09247627
The organism is human, or “hsapiens”. The ontology is set to “BP” again. In this case,
all biological process gene sets, regardless of size, are included in the analysis. Thus, the
appropriate function call is:
> example2a <- profileTable(gene.names2, contrasts2a, pvals2,
+ gene.ID ="affy", organism = "hsapiens",
+ ontology = "BP", affy.chip = "hgu133plus2")
Table 2.9 shows the output from profileTable. The output shows that 10,714 gene sets
(biological processes) show no significant difference between any of the dosed groups and
the control for either cell line. Also, using row 15 as an example, 20 gene sets have the
profile that, for the RS4 cell line, they are significantly less active in both dosed groups,
compared to control, with no significant difference between either dosage level and control
for the SEMK2 cell line. Suppose this profile (-1, -1, 0, 0) is of particular interest. To see
which 20 biological processes fit that profile, pickOut can be used again. The profile of
interest is in the 15th row. With only one stratum, the correct function call is:
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RS4Low RS4High SEMK2Low SEMK2High BP
0 0 0 0 10714
0 0 0 1 340
1 0 0 1 191
0 0 1 1 159
1 0 0 0 149
1 1 0 1 114
1 1 1 1 106
1 0 1 1 92
0 0 1 0 71
0 0 0 -1 68
-1 -1 0 -1 46
0 0 -1 -1 39
0 -1 0 0 31
1 1 0 0 31
-1 -1 0 0 20
-1 0 0 0 18
0 -1 1 0 15
-1 0 0 -1 14
-1 -1 -1 -1 8
0 1 1 1 8
0 0 -1 0 7
0 1 0 0 7
0 -1 1 1 5
0 -1 0 -1 2
0 1 0 1 2
-1 -1 1 0 1
-1 0 -1 -1 1
0 1 1 0 1
Table 2.9: output from profileTable for second example:
> gene.sets <- pickOut(example2a, 15, 1)
[1] "GO:0001510" "GO:0006400" "GO:0006417" "GO:0006431" "GO:0006437"
[6] "GO:0006564" "GO:0006839" "GO:0007005" "GO:0008614" "GO:0008615"
[11] "GO:0009225" "GO:0009396" "GO:0009451" "GO:0031247" "GO:0032543"
[16] "GO:0034975" "GO:0042819" "GO:0055129" "GO:0071301" "GO:0071494"
This gives the GO ID’s of the 20 gene sets that fit the profile of interest. Next suppose
a GO graph of those 20 processes is desired. Figure 2.2 shows the desired graph, generated
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by the function call:
> graphCell(example2a, 15, 1, interact = FALSE, print.legend = FALSE)
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Fig. 2.2: GO graph showing the 20 gene sets that fit the profile -1 -1 0 0 within the framework
of all parent GO BP terms
Lastly, suppose the gene sets GO:0001510 and GO:0006171 are of particular interest.
Go2Profile can gives results for both of those at the same time.
> profiles <- go2Profile(c("GO:0001510", "GO:0006171"), example2a)
Tables 2.10 and 2.11 show the resulting tables. In this case, this verifies the result
from pickOut that GO:0001510 has the profile -1, -1, 0, 0 (consensus less active in both
dosage levels compared to control in the RS4 cell line), and it shows that GO:0006171 has
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$`GO:0001510`
RS4Low RS4High SEMK2Low SEMK2High BP
-1 -1 0 0 1
Table 2.10: Table showing profile of the gene set GO:0001510
$`GO:0006171`
RS4Low RS4High SEMK2Low SEMK2High BP
1 1 0 0 1
Table 2.11: Table showing profile of the gene set GO:0006171
the profile 1, 1, 0, 0 (consensus more active in both dosage level compared to control in the
RS4 cell line).
2.6.3 Motivating Example 2b
Another way to look at the second motivating example is to let the dosages of the drug
obatoclax (low and high) be the dimensions of the profiles and let the cell lines be strata.
This way, within each strata, or cell line, each biological process fits into one of the profiles.
Looking at the problem this way, contrasts2b would contain:
[1] "Low.RS4" "High.RS4" "Low.SEMK2" "High.SEMK2"
gene.names2 and pvals2 are the same objects used in Section 2.6.2. The correct func-
tion call is still the same as before, except using contrasts2b instead of contrasts2a.
> example2b <- profileTable(gene.names2, contrasts2b, pvals2,
+ gene.ID ="affy", organism = "hsapiens",
+ ontology = "BP", affy.chip = "hgu133plus2")
Table 2.12 shows the output from profileTable. The output shows that 11,398 gene sets
of biological processes show no significant difference between either of the dosage levels and
the control for the RS4 cell line, and 10,970 biological processes show no significance for
the SEMK2 cell line. Also, using row 7 as an example, 33 gene sets have the profile that
33
Low High RS4 SEMK2
0 0 11398 10970
0 1 18 647
1 1 251 370
1 0 432 88
0 -1 53 130
-1 -1 75 48
-1 0 33 7
Table 2.12: output from profileTable for second example, part 2:
they are significantly less active for a low dosage of obatoclax compared to control, with no
significant difference for a high dose for the RS4 cell line, and 7 gene sets have that same
profile for the SEMK2 cell line.
The function calls for pickOut and graphCell will also be the same as before, except
now the user must specify a stratum: column 1 for the RS4 cell line or column 2 for the
SEMK2 cell line. Looking at the -1, 0 profile for the SEMK2 cell line, the correct function
calls are (Figure 2.3 shows the desired graph):
> gene.sets <- pickOut(example2b, 7, 2)
[1] "GO:0006813" "GO:0043266" "GO:0043268" "GO:0048745" "GO:0051481"
[6] "GO:0071526" "GO:0090075"
> graphCell(example2b, 7, 2, interact = FALSE, print.legend = FALSE)
The call for go2Profile doesn’t change at all, but looking at GO:0006813 does provide
an interesting example because it fits different profiles for the 2 strata.
> profiles <- go2Profile(c("GO:0006813"), example2b)
Table 2.13 shows that this biological process has no significant difference between ei-
ther dosage level and control in the RS4 cell line. However, it is significantly less active for
low dose versus control in the SEMK2 cell line and not significantly different for high dose
versus control in the SEMK2 cell line.
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Fig. 2.3: GO graph showing the 7 gene sets that fit the profile -1 0 within the framework
of all parent GO BP terms
$`GO:0006813`
Low High RS4 SEMK2
0 0 1 0
-1 0 0 1
Table 2.13: Table showing profile of the gene set GO:0006813
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Chapter 3
Discussion
3.1 Summary
The package mvGST is independent of platform (for collecting gene expression data)
and experimental design. It offers a novel approach to gene set testing, allowing for multi-
variate and directional comparisons of GO activity levels (using expression of gene sets as
proxy). The package mvGST offer tools for summarizing the results and visualizing gene
sets that have similar results in the multivariate and directional comparisons.
3.2 Noteworthy Challenges
The most difficult challenges in the construction of this package all had to do with
making sure the genes could be mapped to Gene Ontology correctly, regardless of the
original gene name database used.
3.2.1 Gene Name Translation
The code for a package, like mvGST, needs to be as generalizable as possible. For most
aspects of the package, this required no more than using variables instead of constants.
However, mapping genes to Gene Ontology was much more complicated. There are many
databases of gene names and the tools for mapping to Gene Ontology are only available for
a few of them. The package topGO provides a mapping from Affymetrix and Entrez, along
with a few others [27], but there are many more possibilities that must be accounted for.
The package gProfileR provides mappings to and from numerous databases [28]. gProfileR
is capable of mapping directly to Gene Ontology, but testing showed that this took too much
time to be practical (see Section 1.5.1). That is why mvGST uses gProfileR to translate
genes to Entrez, and then uses topGO to create a list of gene sets that map from Entrez to
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Gene Ontology. This translation creates two problems: multiple genes translating to one
gene (many-to-one), and one gene translating to multiple genes (one-to-many).
3.2.2 Many-to-One
With multiple p-values being combined into one, this seems like a perfect time to
use a p-value combination method. Stouffer’s method [21] is an option, but it may be
inappropriate in this case. Since the multiple p-values are being combined because Entrez
considers them to be from the same gene, it is reasonable to believe that the corresponding
genes do not act independently. If two or more genes are so closely connected that they
can reasonably be considered to be a single gene (and the reason the many-to-one issue
happens is because Entrez considers more than one gene to really just be a single gene),
then it is certainly possible that they do not act, or are not expressed, independently.
Even though the resulting p-values are statistically independent, the potential underlying
biological dependence may cause Stouffer’s method to overstate the significance of the gene
(the single Entrez ID). In this case (that the genes are not expressed independently), it
seems most likely that a positive dependence structure exists. If this is a real problem, then
Hartung’s [33] p-value combination method is a viable option.
3.2.2.1 Hartung’s Method
Hartung’s modified inverse normal method [33] accounts for a constant, positive de-
pendence structure between the p-values. If all of the weights are set to 1, the test statistic
is:
t(γˆ?, κ) =
∑n
i=1 ti√
n+ (n2 − n)[γˆ? + κ√2/(n+ 1)(1− γˆ?)] (3.1)
where γˆ? = max[−1/(n − 1), γˆ], γˆ = 1 −∑ni=1(ti −∑nj=1 tj/n)2/(n − 1), κ = 0.1(1 +
1/(n − 1) − γˆ?, and ti is the normal quantile of the ith one-sided p-value. Under the
null hypothesis, this test statistic approximately follows the standard normal distribution.
Hartung also suggested the κ = 0.2 could be used. In his simulation, which choice of κ
was better depended on the dependency structure of the p-values. In this package, κ =
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0.1(1 + 1/(n − 1) − γˆ? is used because κ = 0.2 tends to be overly conservative at times,
based on Hartung’s simulations [33].
Hartung showed, via simulation study, that even when the assumption of constant
dependence was violated, his method still performed relatively well and did a better job
than Stouffer’s method [33]. In the case of gene translation, if there are only 2 p-values
being combined this way (which is the most common scenario), then the dependence can be
considered constant. If there are more than 2, there is no way to know if the assumption is
met, but Hartung’s method should still perform reasonably well, based on his simulations
involving p-values that did not have constant dependence [33].
3.2.2.2 Hartung’s versus Stouffer’s
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Fig. 3.1: Scatter plot of Hartung combined p-values versus Stouffer combined p-values
In theory, arguments can be made for both Hartung’s and Stouffer’s methods for com-
bining p-values from the many-to-one problem. The fact that the p-values are statistically
independent favors Stouffer’s method, but the potential underlying biological dependence fa-
vors Hartung’s method. To compare these methods, gene names from the second motivating
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Fig. 3.2: Scatter plot of Hartung combined p-values versus Stouffer combined p-values when
the estimated covariance is positive
example (Section 2.6.2) were translated to Entrez ID’s (this is for the sake of demonstration,
since the gene names in the second motivating example were Affymetrix ID’s that could
already be easily mapped to GO). In this example, there were 10,933 cases of the many-
to-one problem. For each of those cases the Hartung combined p-value and the Stouffer
combined p-value were computed, as well as the number of p-values being combined and
the covariance estimate (assuming constant covariance), which is used to compute Hartung’s
test statistic. Figure 3.1 shows the plot of Hartung combined p-values versus Stouffer com-
bined p-values with lines added at the significance thresholds (0.025 and 0.975) and points
colored by local density. Sometimes Hartung’s method is more conservative and sometimes
Stouffer’s method is more conservative. Figure 3.2 shows that when the estimated covari-
ance of the p-values being combined is positive (cases when Hartung’s method is most likely
to be appropriate), Stouffer’s method tends to produce more extreme p-values (closer to 0
or 1), which may be an overstatement of a gene’s true significance. Figure 3.3, however,
shows that when the estimated covariance of the p-values being combined is negative (cases
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Fig. 3.3: Scatter plot of Hartung combined p-values versus Stouffer combined p-values when
the estimated covariance is negative
when Hartung’s method is least likely to be appropriate), Hartung’s method tends to pro-
duce more extreme p-values, which may be a result of the negative covariance (which is
a violation of the assumptions for Hartung’s method) and not the true significance of the
corresponding gene.
Since comparing the resulting combined p-values from Hartung’s method and Stouffer’s
method does not strongly favor either method, it may be useful to look at the estimated
(constant) covariance (or γˆ?) of each group of p-values that was combined. Figure 3.4 shows
that most of the estimated covariances are positive, but many of them are negative, too. If
Hartung’s method was appropriate (if there was a significant degree of biological dependence
between genes whose p-values were being combined), then one would expect almost all of
the estimated covariances to be positive. It is also concerning that there are small spikes
of covariances at a couple of negative values, most notably near -1. One way to determine
if these covariance estimates are likely to be produced by biologically dependent genes is
to compare them to covariances that were estimated from simulated p-values that have no
40
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Fig. 3.4: Histogram of observed estimated covariances
possible biological dependence. Groups of p-values (following a uniform distribution) were
simulated such that the groups of simulated p-values were of the same size as the groups
of actual p-values combined (e.g. in the observed data there were 5480 groups with 2 p-
values, so in the simulated data there were also 5480 groups with 2 p-values). Figure 3.5
shows that the overall shape of the histogram of simulated covariance estimates is somewhat
similar to the shape of the histogram of observed covariance estimates. The spikes at -1
and -0.5 are taller in the histogram produced from simulated data, and the spike at 1 is
taller in the histogram produced from the observed data. Overall, the observed data have
more positive covariance estimates, which supports the use of Hartung’s method. There
are, however, still a sizable number (about 500) of observed covariance estimates near -
1, for which Hartung’s method would be inappropriate. Although this data set provides
some evidence supporting the idea of biological dependence (and, therefore, the possible
overstatement by Stouffer’s method of significance for the corresponding genes), there is
also some evidence that using Hartung’s method would not be appropriate for all cases of
the many-to-one problem. With a lack of overwhelming evidence in favor either Stouffer’s
or Hartung’s method, mvGST offers Stouffer’s method as a solution to the many-to-one
problem because the platform chosen by the researcher (to measure gene expression levels)
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Fig. 3.5: Histogram of simulated estimated covariances
considers the many genes (of the many-to-one) to be separate, independently expressed
genes. If those genes are independently expressed, then Stouffer’s method is the most
appropriate way to combine the corresponding p-values.
3.2.3 One-to-Many
Ignoring the one-to-many problem artificially creates more p-values than there were
tests. Also, the duplicated p-values are likely to end up in the same gene sets which would
grossly violate the assumption of independence in Stouffer’s method. The only way to return
to the correct number of p-values is to eliminate all but one of the genes that the original gene
translated to. In mvGST, the first gene listed by gconvert is the one that is not eliminated.
This forces the translation to be one to one which resolves the above problems. However,
bias is possible if there is something systematically different about the first genes. This
solution also creates a loss of information. If the original gene name maps to multiple new
names, there must be a biological reason for that. It is up to the researcher to decide which
is worse: possibly significant loss of information (because genes were arbitrarily ignored),
or possibly significant violation of statistical assumptions (because, when the p-values are
combined with Stouffer’s method for each gene set, p-values that are 100% dependent will
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be treated like they are independent).
3.3 Possible Future Extensions
Two concerns that could be resolved with future research or extensions are: the pos-
sible over-conservativeness of the Benjamini-Yekutieli adjustment, and the violation of the
assumption of independence in Stouffer’s p-value combination method.
The Benjamini-Yekutieli adjustment [25] for multiple hypothesis tests accounts for any
type of dependency in controlling the false discovery rate [24]. The focus level adjustment
[26] specifically accounts for the Gene Ontology structure in controlling the family-wise error
rate. Even though the focus level adjustment controls the family-wise type I error rate, not
the FDR, it may be a preferred adjustment because of the advantage of taking into account
the relationship between parent and child gene sets. One disadvantage of the focus level
adjustment is the amount of time that it takes to run. It may be possible in the future to
incorporate the focus level adjustment in a way that does not take an unreasonable amount
of time [34].
Since mvGST starts with p-values provided by the user, there is no current way to
account for the unknown dependency structure within those p-values. Because this depen-
dency violates one of the assumptions of Stouffer’s method, this is an area that could be
improved in the future. It may be impossible to account for all possible analyses that create
those p-values (due to the infinite range of possible experimental designs), but one possible
extension of this package could be to provide a few ways of generating those p-values. If
the user used mvGST to perform the original analysis, then a monte carlo simulation could
be used to account for the dependency. This would be very computationally expensive, but
it may be worth the time for some users.
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mvGST Code
profileTable <-
function(gene.names, contrasts, pvals, list.groups = NULL, sig.level = .05,
gene.ID, organism, affy.chip, ontology = "BP", method = 1,
minsize = 1, maxsize = Inf){
# Takes a matrix of p-values and returns a table with the number of gene sets
# that fall into each possible profile
#
# Args:
# gene.names: A character vector containing the gene names that correspond
# to the rows of the matrix of p-values
# contrasts: A character vector containing the contrasts that correspond to
# each column in the matirx of p-values. Must be in 1 of 2 formats:
# Var1.Var2 or Var1
# pvals: A matrix containing the p-values corresponding to the various genes
# and contrasts
# list.groups: An optional list containing user-defined gene sets
# sig.level: The alpha level that should be used. Default is .05.
# gene.ID: Gene naming system used for the gene names. Used to generate list
# of gene sets mapping genes to Gene Ontology sets
# organism: The organism that the genes come from. Used to generate list
# of gene sets mapping genes to Gene Ontology sets
# affy.chip: The type of affy.chip used, if gene.ID == "affy".
# ontology: The ontolgy that should be used for gene sets: BP, MF, or CC
# method: The method for handling gene name tranlation issues
# minsize: The minimum size gene set that will be included in the list
# maxsize: The maximum size gene set that will be included in the list
#
# Returns:
# The primary return is a table containing the number of gene sets that fall
# into each of the possible significance profiles
if (!is.matrix(pvals)){
stop("pvals must be a matrix")
}
# adding ".BP" to contrasts if in the form Var1
vars <- length(unlist(strsplit(contrasts[1], "[.]")))
if (vars == 1){
contrasts <- paste(contrasts, ontology, sep = ".")
}
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# accounting for the possibilities of 1's and 0's in the p-values
f.one <- 1-.Machine$double.eps
f.zero <- .Machine$double.eps
pvals <- ifelse(pvals == 1, f.one, pvals)
pvals <- ifelse(pvals == 0, f.zero, pvals)
if (is.null(list.groups)){
if (any(gene.ID == c("affy", "entrez", "genbank", "alias", "ensemble",
"symbol", "genename", "unigene")) != TRUE){
# Converts gene names to entrez database that can be mapped directly to GO.
old.names <- character()
new.names <- character()
# gene names are converted 1000 at a time because doing more than that
# may cause an error (vector too large)
for (i in 0:floor(length(gene.names) / 1000)){
low <- i * 1000 + 1
high <- (i + 1) * 1000
if (high > length(gene.names)){
high <- length(gene.names)
}
gene.names <- toupper(gene.names)
converted1 <- gconvert(gene.names[low:high], target = "ENTREZGENE_ACC")
old.names <- c(old.names, as.character(converted1$alias))
new.names <- c(new.names, as.character(converted1$target))
}
# trimming all-numeric ID's down to just the numbers
if(grep("^[[:digit:]]+$", str_trim(gene.names[1])) == 1){
all.numeric <- TRUE
}
new.genes <- cbind(old.names, new.names)
new.genes[, 2] <- gsub("ENTREZGENE_ACC:", "", new.genes[, 2])
if (all.numeric){
new.genes[, 1] <- substr(new.genes[, 1],
regexpr("[[:digit:]]+$", new.genes[, 1]),
nchar(new.genes[, 1]))
}
# eliminating duplicate rows (i.e., both the new and old gene names
# are the same)
duplicate <- rep(FALSE, length(new.genes[, 1]))
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for (i in 2:length(new.genes[, 1])){
duplicate[i] <- ifelse(all(new.genes[i, ] == new.genes[i-1, ]), TRUE, FALSE)
}
new.genes <- new.genes[!duplicate, ]
converted <- geneNameConvertRows(pvals, gene.names, new.genes, method)
pvals <- converted$p.mat
gene.names <- converted$genes
gene.ID <- "entrez"
}
# generates list of gene sets
list.groups1 <- generateGeneSets(ontology=ontology, species = organism,
ID = gene.ID, affy.chip)
offspring <- get("as.list", pos = "package:AnnotationDbi")(get(paste("GO", ontology, "OFFSPRING", sep = "")))
list.groups <- sapply(1:length(offspring),
function(x) fillInList(list.groups1[[names(offspring[x])]],
names(offspring)[x],
offspring, list.groups1))
names(list.groups) <- names(offspring)
size <- sapply(list.groups, length)
keepers <- (size <= maxsize & size >= minsize)
list.groups <- list.groups[keepers]
}
# Creates MVGST object
pmat <- mvGSTObject(gene.names, contrasts, pvals, list.groups)
# Converts p-values matrix for genes to a p-value matrix for gene sets
grouped.pmat <- separate(pmat, list.groups)
# Perform Benjamini-Yekutieli adjustment for multiple hypothesis testing
by.adjusted <- oneSideBYAdjust(grouped.pmat)
# Creates the final output
one.zero <- changeTO10(by.adjusted, sig.level=.05)
almost.final <- finalResults(one.zero)
near.final <- cut(almost.final)
final <- mvSort(near.final)
return(final)
}
pickOut <-
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function(mvgst, row, col = 1){
# Return the gene sets that are included in a specific cell of the final
# results table of a mvGST object.
#
# Args:
# mvgst: A mvGST object with a final results table.
# row: The row of the desired cell.
# column: The column of the desired cell.
#
# Returns:
# A character vector containing the gene sets in the desired cell.
table <- mvgst$results.table
raw.profile <- dimnames(table)[[1]][row]
temp <- substr(raw.profile, 3, nchar(raw.profile) - 1)
temp2 <- as.integer(strsplit(temp, ",")[[1]])
the.profile <- matrix(temp2, nrow = 1)
observed <- profileCombine(mvgst$ones.zeroes)[[col]]
t <- apply(observed, MARGIN = 1, FUN = function(x) all(x == the.profile))
sets <- mvgst$group.names[!is.na(t) & t]
return(sets)
}
graphCell <-
function(object, row, col = 1, ontology = "BP", interact = TRUE, legend.pos = "bottomleft",
print.legend = TRUE){
# Graphs the gene sets from a given cell of the final results table
# of a mvGST object.
#
# Args:
# object: A mvGST object with a final results table.
# row: The row of the desired cell.
# colomn: The column of the desired cell.
# ontology: The ontology, within Gene Ontology, that should be used ("BP", "MF", "CC").
# interact: Indicates whether or not the graph should be interactive.
# legend.pos: If interactive, indicates the desired position of the legend.
# print.legend: Indicates if the legend should also be printed separately
sets <- pickOut(object, row, col)
if (ontology == "BP"){
g.sub <- GOGraph(sets, GOBPPARENTS)
} else {
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if (ontology == "MF"){
g.sub <- GOGraph(sets, GOMFPARENTS)
} else {
if (ontology == "CC"){
g.sub <- GOGraph(sets, GOCCPARENTS)
} else {
stop("invalid ontology")
}
}
}
g.sub <- removeNode("all",g.sub)
interactiveGraph(g.sub, sets, interact, legend.pos, print.legend)
}
go2Profile <-
function(names, object){
# Performs the same operation as go2GeneSet, but for multiple gene sets
#
# Args:
# names: A character vector with the names, ID's, of the gene sets
# of interest.
# object: A mvGST object with a final results table.
#
# Returns:
# A list of matrices. Each matrix has possible profiles as the
# row names and contrasts as the column names. Ones in the appropriate
# cells showing which profile the gene set fit for each contrast and
# zeroes elsewhere.
result <- lapply(names, go2GeneSet, object)
list.results <- list()
temp <- list(results.table = NULL, ord.lev = NULL)
temp$ord.lev <- object$ord.lev
for (i in 1:length(result)){
temp$results.table <- result[[i]]
class(temp) <- "mvGST"
temp1 <- cut(temp)
list.results[[i]] <- temp1
}
names(list.results) <- names
return(list.results)
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}
separate <- function(pmat, list.groups){
# Uses Stouffer's method to combine p-values for gene sets
#
# Args:
# pmat: An MVGST object with a matrix of p-values with corresponding
# gene names as the row names
# list.groups: A list of character vectors containing the gene sets
#
# Returns:
# An MVGST object with a matrix of p-values with corresponding gene
# set names st the row names
mvgst <- pmat$raw.pvals
new.ps <- matrix(NA, nrow = length(list.groups), ncol = ncol(mvgst))
for (i in 1:length(list.groups)){
t <- is.element(rownames(mvgst), list.groups[[i]])
if (any(t)){
new.ps[i, ]<- apply(matrix(mvgst[t, ], nrow = sum(t)), MARGIN = 2, FUN = combinePvalues)
}
}
new.ps <- matrix(new.ps, dimnames = list(rep(1:nrow(new.ps)),
colnames(mvgst)),
nrow = nrow(new.ps))
pmat$grouped.raw <- new.ps
return(pmat)
}
finalResults <- function(pmat){
# Takes a matrix of significance results (-1, 0, 1) and creates a table
# with the total number of gene sets that fall into each possible
# profile
#
# Args:
# pmat: An MVGST object containing the matrix of ones, zeroes, and
# negative ones indicating whether each gene set is
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# significantly less differentially expressed, not
# significantly differentially expressed, or significantly
# greater differentially expressed for each contrast
#
# Returns:
# An MVGST object containing a matrix with row names that are each
# possible significance profile for the first variable, column names
# that are each combination of the remaining variables, and cell
# values that indicate the number of gene sets that have the
# corresponding significance profile.
mat <- pmat$ones.zeroes
# setting up the final results matrix
profile <- profiles(mat)
columns <- tableColumns(mat)
observed <- profileCombine(mat)
profs <- as.list(rep(NA, nrow(profile)))
# counting the number of gene sets that fit in each cell of matrix
for (i in 1:nrow(profile)){
profs[[i]] <- profile[i,]
}
final <- matrix(NA, nrow = nrow(profile), ncol = length(columns),
dimnames = list(profs, columns))
for (i in 1:nrow(final)){
for (j in 1:ncol(final)){
final[i,j] <- sum(apply(observed[[j]], MARGIN = 1, FUN = function(x) all(x == profile[i,])), na.rm = TRUE)
}
}
pmat$results.table <- final
pmat$ord.lev <- dimnames(profile)[[2]]
pmat$contrasts <- dimnames(final)[[2]]
return(pmat)
}
profiles<-function(mat){
# Takes a matrix of significance results (-1, 0, 1) and creates a matrix
# with each row being a possible significance profile and the number of
# rows being equal to the number or possible significance profiles.
#
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# Args:
# mat: A matrix with column names that are the in the format
# Var1.Var2.Var3...Var(n-1).Var(n) that represent the contrasts
# being tested.
#
# Returns:
# A matrix with each row being a possible significance profile and the
# number of rows being equal to the number or possible significance
# profiles.
names <- dimnames(mat)[[2]]
prof <- rep(NA, length(names))
for (i in 1:length(names)){
prof[i] <- unlist(strsplit(names[i], "[.]"))[1]
}
t <- duplicated(prof)
unique <- prof[!t]
nprofiles <- 3 ^ length(unique)
profiles <- matrix(rep(NA), ncol = length(unique),
nrow = nprofiles,
dimnames = list(rep(1:nprofiles), unique))
for (i in 1:length(unique)){
profiles[, i] <- rep(c(rep(-1, nprofiles / 3 ^ i),
rep(0, nprofiles / 3 ^ i),
rep(1, nprofiles / 3 ^ i)), 3 ^ (i - 1))
}
return(profiles)
}
mvGSTObject <- function(gene.names, contrasts, pvals, groups){
# Creates an object of class mvGST
#
# Args:
# gene.names: A character vector containing the gene names that correspond
# to the rows of the matrix of p-values
# contrasts: A character vector containing the contrasts that correspond to
# each column in the matirx of p-values. Must be in format:
# Var1.Var2.Var3...Var(n-1).Var(n)
# pvals: A matrix containing the p-values corresponding to the various genes
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# and contrasts
# groups: An optional list containing user-defined gene sets
#
# Returns:
# A mvGST object with most things still empty
object <- matrix(pvals, dimnames = list(gene.names, contrasts),
nrow = length(gene.names))
obj <- list(raw.pvals = object,
results.table = matrix(rep(NA,4),nrow=2),
ord.lev = NA,
contrasts = NA,
grouped.raw = NA,
adjusted.group.pvals = NA,
ones.zeroes = NA,
group.names = names(groups))
class(obj) <- "mvGST"
return(obj)
}
tableColumns <- function(mat){
# Takes a matrix of significance results (-1, 0, 1) and returns the
# contrasts that need to be the column names for the final results
# matrix
#
# Args:
# mat: A matrix with column names that are the in the format
# Var1.Var2 or Var1that represent the contrasts
# being tested.
#
# Returns:
# A character vector in the format Var2 or "ontology"
names <- dimnames(mat)[[2]]
col <- rep(NA, length(names))
columns <- rep(NA, length(names))
for (i in 1:length(names)){
col[i] <- unlist(strsplit(names[i], "[.]"))[1]
columns[i] <- substr(names[i], nchar(col[i]) + 2, nchar(names[i]))
}
t <- duplicated(columns)
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unique <- columns[!t]
return(unique)
}
convertPvalues <- function(pvals, relativity, two.sided = TRUE){
# Converts a matrix of p-values from two-sided to one-sided or vice versa.
#
# Args:
# pvals: A matrix of p-values.
# relativity: Only used when two.sided == TRUE. Numeric value that is
# greater than 0 if the one-sided p-value should be less
# than .5.
# two.sided: TRUE if pvals contains two-sided pvalues, FALSE if pvals
# contains one-sided pvalues.
if(two.sided){
newP <- ifelse(relativity < 0, 1 - pvals / 2, pvals / 2)
} else {
newP <- ifelse(pvals < .5, pvals * 2, (1 - pvals) * 2)
}
return(newP)
}
combinePvalues <- function(pvals){
# Uses Stouffer's method to combine p-values
#
# Args:
# pvals: A vector of p-values.
#
# Returns:
# A single combined p-value
comb.p <- pnorm(sum(qnorm(pvals)) / sqrt(length(pvals)))
return(comb.p)
}
profileCombine <- function(mat){
# Takes a matrix of significance results (-1, 0, 1) and list of matrices
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# with each matrix containing the significance profiles for a given
# Var2.Var3...Var(n-1).Var(n)
#
# Args:
# mat: A matrix with column names that are the in the format
# Var1.Var2.Var3...Var(n-1).Var(n) that represent the contrasts
# being tested.
#
# Returns:
# list of matrices with each matrix containing the significance
# profiles for a given Var2.Var3...Var(n-1).Var(n)
names <- dimnames(mat)[[2]]
col <- rep(NA, length(names))
duplicates <- rep(NA, length(names))
columns <- tableColumns(mat)
each <- profiles(mat)
mats <- rep(list(matrix(rep(NA), nrow = nrow(mat),
ncol = ncol(each))), length(columns))
for(i in 1:length(columns)){
for (j in 1:length(names)){
col[j] <- unlist(strsplit(names[j], "[.]"))[1]
duplicates[j] <- substr(names[j], nchar(col[j]) + 2, nchar(names[j]))
}
t <- duplicates == columns[i]
mats[[i]] <- matrix(mat[, t], nrow = nrow(mat))
}
return(mats)
}
changeTO10 <- function(pvals.mat, sig.level){
# Converts a matrix of one-sided p-values to matrix of ones, zeroes and
# negative ones where 1 represents significantly greater, 0 represents
# no significance, and -1 represents significantly less than
#
# Args:
# pvals.mat: A mvGST object containing a matrix of one-sided p-values.
# sig.level: Significance level to be used. P-values less than
# sig.level / 2 are converted to 1. P-values greater
# than 1 - sig.level / 2 are converted to -1.
#
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# Returns:
# A matrix of ones, zeroes, and negative ones.
pvals <- pvals.mat$adjusted.group.pvals
ind.profile <- matrix(rep(0), nrow = nrow(pvals), ncol = ncol(pvals),
dimnames = dimnames(pvals))
ind.profile <- ifelse(pvals <= sig.level / 2, 1,
ifelse(pvals >= 1 - sig.level / 2, -1, 0))
pvals.mat$ones.zeroes <- ind.profile
return(pvals.mat)
}
oneSideBYAdjust<-function(pval.mat){
# Converts one-sided p-values to two-sided. Performs a Benjamini-Yekutieli
# adjustment on the two-sided p-values. Converts the adjusted two-sided
# p-values back to one-sided p-values.
#
# Args:
# pval.mat: A mvGST object that contains a matrix of Stouffer combined
# p-values
#
# Returns:
# A mvGST object that also contains a matrix of BY adjusted, Stouffer
# combined p-values.
pvals <- pval.mat$grouped.raw
two.sided <- convertPvalues(pvals, two.sided = FALSE)
two.adjusted <- apply(two.sided, MARGIN = 2, FUN = p.adjust, method = "BY")
relative <- ifelse(pvals < .5, 1, -1)
one.combined <- convertPvalues(two.adjusted, relative)
pval.mat$adjusted.group.pvals <- matrix(one.combined, nrow = nrow(pvals),
dimnames = dimnames(pvals))
return(pval.mat)
}
cut <- function(y){
# Removes the rows with all zeroes from the final results table in a mvGST object.
#
# Args:
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# y: A mvGST object that contains a final results matrix
#
# Returns:
# A mvGST object that contains a final results matrix with no all zero rows
x <- y$results.table
temp.mat <- matrix(0, ncol = ncol(x))
temp.names <- NA
for (i in 1:nrow(x)){
if (sum(x[i,]) != 0){
temp.mat <- rbind(temp.mat, x[i, ])
temp.names <- c(temp.names, dimnames(x)[[1]][i])
}
}
temp.mat <- temp.mat[-1, ]
temp.names <- temp.names[-1]
final.mat <- matrix(temp.mat, ncol = ncol(x),
dimnames = c(list(temp.names), list(dimnames(x)[[2]])))
y$results.table <- final.mat
return(y)
}
mvSort <- function(y){
# Sorts the rows in the final results table in a mvGST object from the greatest
# row total to the least.
#
# Args:
# y: A mvGST object that contains a final results matrix
#
# Returns:
# A mvGST object that contains a final results matrix with rows sorted by
# row total.
x <- y$results.table
temp <- x
row.sum <- apply(temp, MARGIN = 1, FUN = sum)
ranked <- rank(1 / row.sum, ties.method = "first")
for (i in 1:nrow(temp)){
x[ranked[i], ] <- temp[i, ]
dimnames(x)[[1]][ranked[i]] <- dimnames(temp)[[1]][i]
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}
y$results.table <- x
return(y)
}
print.mvGST <- function(x, ...){
# Prints an object of class mvGST
#
# Args:
# x: A mvGST object
if (is.na(x$results.table[1, 1])){
print(x$raw.pvals)
} else {
y <- x$results.table
col.names1 <- dimnames(y)[[2]]
col.names <- ifelse(nchar(col.names1) < 4, paste(col.names1, " "), col.names1)
row.spaces <- nchar(col.names)
row.names <- dimnames(y)[[1]]
col.spaces <- max(nchar(row.names))
for (i in 1:length(row.names)){
temp.name <- substr(row.names[i], 3, nchar(row.names[i])-1)
row.names[i] <- " "
counter <- 1
for (j in 1:nchar(temp.name)){
char <- substr(temp.name, j, j)
if (char == "-"){
row.names[i] <- paste(row.names[i], char, sep = "")
} else {
if (char == "0"){
row.names[i] <- paste(row.names[i], char)
for (k in 1:nchar(x$ord.lev[counter])){
row.names[i] <- paste(row.names[i], "")
}
counter <- counter + 1
} else {
if (char == "1"){
if (substr(temp.name, j - 1, j - 1) == "-"){
row.names[i] <- paste(row.names[i], char, sep = "")
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} else {
row.names[i] <- paste(row.names[i], char)
}
for (k in 1:nchar(x$ord.lev[counter])){
row.names[i] <- paste(row.names[i], "")
}
counter <- counter + 1
}
}
}
}
}
row.names <- gsub(",", " ", row.names)
col.spaces <- max(nchar(row.names))
cat(" ")
for (i in 1:length(x$ord.lev)){
cat(x$ord.lev[i], " ")
}
cat(col.names, "\n")
for (i in 1:length(row.names)){
cat(row.names[i], "")
for (j in 1:ncol(y)){
spaces <- 1 + row.spaces[j] - nchar(y[i, j])
cat(y[i, j], rep("", max(spaces, 1)))
}
cat("\n")
}
}
}
summary.mvGST <-
function(object, ...){
# Creates a summary of the mvGST object, giving number of gene sets tested,
# levels of the ordered factor, number of other factors, number of possible
# profiles, number of profiles that have gene sets, and number of contrasts
# tested.
#
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# Args:
# object: A mvGST object
y <- object$results.table
gene.sets <- sum(y[, 1])
ordered.vars <- length(object$ord.lev)
summ <- c(gene.sets, 3 ^ ordered.vars, nrow(y), ncol(y))
class(summ) <- "summary.mvGST"
return(summ)
}
print.summary.mvGST <- function(x, ...){
# Prints an object of class summary.mvGST
#
# Args:
# x: A summary.mvGST object
cat("", x[1], "gene sets \n", x[4], "possible profiles \n",
x[5], "profiles used \n", x[6], "strata \n")
}
geneNameConvertRows <- function(pvals, gene.names, new.names, method = 1){
# Handles translation from one set of gene names to another.
#
# Args:
# pvals: A matrix of p-values.
# gene.names: A character vecter containing the original gene names.
# new.names: A matrix with the first column containing the original gene
# names, and the second column containing the corresponding new
# names.
# method: A number from 1 to 4 that indicates what method should be used to
# handle duplicates in the name translation.
# Method 1 does nothing. As a result, some rows of p-values will be
# duplicated when one name translates to many. Some rows will also
# have the same gene name when many names translate to just one.
# Method 2 uses Hartung's modified inverse normal method to combine
# p-values when many names translate to just one.
# Method 3 accounts for when one name translates to many. Instead of
# duplicating rows of p-values, only the first of the new names is
# used.
# Method 4 combines methods 2 and 3. First method 2 is performed, then
63
# method 3.
#
# Returns:
# A list containing the new p-value matrix, the new gene names, and the old
# gene names if method != 1.
if (method == 1){
new.pvals <- matrix(NA, nrow = nrow(new.names), ncol = ncol(pvals))
for (i in 1:nrow(new.names)){
new.pvals[i, ] <- pvals[new.names[i, 1] == gene.names]
}
return(list(p.mat = new.pvals, genes = new.names[, 2]))
}
if (method == 3){
return(method3(pvals, gene.names, new.names))
}
if (method == 2){
return(method2(pvals, gene.names, new.names))
}
if (method == 4){
method.two <- method2(pvals, gene.names, new.names)
new.new.names <- data.frame(method.two$old.names, method.two$genes)
return(method4(method.two$p.mat, method.two$old.names, new.new.names))
}
}
hartung <- function(pvals){
# Uses Hartung's modified inverse normal method to combine a set of
# p-values
#
# Args:
# pvals: A vector of p-values
#
# Returns:
# A single p-value.
n <- length(pvals)
t <- qnorm(pvals)
rho.hat <- 1 - sum((t - sum(t) / n) ^ 2) / (n - 1)
rho.hat.star <- max(-1 / (n - 1), rho.hat)
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kappa <- .1 * (1 + 1 / (n-1) - rho.hat.star)
combined.test.statistic <- sum(t) /
sqrt(n + (n ^ 2 - n) *
(rho.hat.star + kappa * sqrt(2 / (n+1)) * (1 - rho.hat.star)))
return(pnorm(combined.test.statistic))
}
method3 <- function(pvals, gene.names, new.names){
# Accounts for the one-to-many gene name translation issue
# by only using the first of the many new names that are
# possible.
#
# Args:
# pvals: A matrix of p-values.
# gene.names: A character vector with the old gene names
# new.names: A data frame with old gene names in the first
# column and corresponding new gene names in the
# second column.
#
# Returns:
# A list with the new matrix of p-values and the corresponding
# gene names.
new.names <- new.names[order(new.names[, 1]), ]
index <- rep(TRUE, nrow(new.names))
for (i in 2:length(new.names[, 1])){
if (any(new.names[i, 1] == new.names[1:(i - 1), 1])){
index[i] <- FALSE
}
}
trunc.new.names <- new.names[index, ]
new.pvals <- matrix(NA, nrow = length(index), ncol = ncol(pvals))
for (i in 1:length(index)){
if (index[i]){
new.pvals[i, ] <- pvals[new.names[i, 1] == gene.names]
}
}
new.pvals <- new.pvals[!is.na(new.pvals[, 1]),]
return(list(p.mat = new.pvals, genes = trunc.new.names[, 2]))
}
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method2 <- function(pvals, gene.names, new.names){
# Accounts for the many-to-one gene name translation issue
# by using Stouffer's inverse normal method to combine
# the p-values
#
# Args:
# pvals: A matrix of p-values.
# gene.names: A character vector with the old gene names
# new.names: A data fram with old gene names in the first
# column and corresponding new gene names in the
# second column.
#
# Returns:
# A list with the new matrix of p-values and the corresponding
# gene names.
new.names <- new.names[order(new.names[, 2]), ]
trunc.new.names <- unique(new.names[, 2])
matches <- rep(0, nrow(new.names))
temp.names <- c("NOT A GENE", as.character(new.names[, 2]), "NOT A GENE")
for (i in 2:(length(temp.names) - 2)){
if (temp.names[i] == temp.names[i + 1] & temp.names[i] != temp.names[i - 1]){
j <- 1
k <- i
while (temp.names[k] == temp.names[k + 1]){
j <- j + 1
k <- k + 1
}
matches[i - 1] <- j
}
}
old.names <- character(length(trunc.new.names))
new.p.mat <- matrix(NA, ncol=ncol(pvals), nrow=length(trunc.new.names))
j <- 1
k <- 0
for (i in 1:length(matches)){
if (j > i) {k <- k + 1; next}
if (matches[i] == 0){
new.p.mat[i-k,] <- pvals[gene.names == new.names[j, 1]]
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old.names[i-k] <- new.names[j, 1]
j <- j + 1
} else {
originals <- new.names[new.names[j,2] == new.names[,2], 1]
temp <- rep(FALSE, length(gene.names))
for (l in 1:length(originals)){
if (any(originals[l] == gene.names)){
temp[originals[l] == gene.names] <- TRUE
}
}
if (!is.matrix(pvals[temp, ])){
new.p.mat[i-k,] <- combinePvalues(pvals[temp,])
} else {
new.p.mat[i-k,] <- apply(pvals[temp, ], MARGIN = 2,
FUN = combinePvalues)
}
old.names[i] <- paste("other", as.character(i))
j <- j + matches[i]
}
}
old.names <- old.names[!is.na(old.names) & old.names != ""]
return(list(p.mat = new.p.mat, genes = trunc.new.names, old.names = old.names))
}
method4 <- function(pvals, gene.names, new.names){
# Does what method3 does, but for a p-value matrix that has already
# gone through method2.
#
# Args:
# pvals: A matrix of p-values.
# gene.names: A character vector with the old gene names
# new.names: A data fram with old gene names in the first
# column and corresponding new gene names in the
# second column.
#
# Returns:
# A list with the new matrix of p-values and the corresponding
# gene names.
temp <- new.names
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new.names <- new.names[order(temp[,1]),]
gene.names <- gene.names[order(temp[, 1])]
pvals <- pvals[order(temp[, 1]), ]
if (!is.matrix(pvals)){
pvals <- matrix(pvals)
}
old.names <- c("NOT A GENE", gene.names, "NOT A GENE")
keepers <- logical()
for (i in 2:(length(old.names) - 1)){
if (old.names[i] != old.names[i - 1] & old.names[i] != old.names[i + 1]){
keepers[i - 1] <- TRUE
} else {
keepers[i - 1] <- FALSE
}
}
keepers[length(keepers) + 1] <- TRUE
k <- 0
j <- 1
for (i in 1:(length(keepers) - 1)){
if (keepers[i] == TRUE){
next
} else {
if (k >= i){
next
} else {
j <- 1
while (!keepers[i + j]){
j <- j + 1
}
keepers[i] <- TRUE
k <- i + j - 1
}
}
}
keepers <- keepers[-length(keepers)]
return(list(p.mat = pvals[keepers, ], genes = new.names[keepers, 2]))
}
generateGeneSets <- function(ontology, species, ID, affy.chip){
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# Generates a list of gene sets based on gene ontology.
#
# Args:
# ontology: The specific ontology within to be used. Either
# "BP", "MF", or "CC".
# species: The organism being studied. It is made up of the
# first letter of the scientific name and the last
# word of the scientific name. For example, human is
# "hsapien"
# ID: The naming system being used on the genes
# affy.chip: If ID = "affy", this is the specific chip that was
# used
#
# Returns:
# A list of character vectors. Each vector contains the names
# of the genes in a set. The names of the elements of the list
# are the Gene Ontology ID's for each gene set.
if (ID == "affy"){
gene.set.list <- annFUN.db(ontology, affyLib = affy.chip)
return(gene.set.list)
} else {
### define species info with species.db <- ###
if (species == "agambiae"){species.db <- "org.Ag.eg.db"}else
if (species == "athaliana"){species.db <- "org.At.tair.db"}else
if (species == "btaurus"){species.db <- "org.Bt.eg.db"}else
if (species == "celegans"){species.db <- "org.Ce.eg.db"}else
if (species == "cfamiliaris"){species.db <- "org.Cf.eg.db"}else
if (species == "dmelanogaster"){species.db <- "org.Dm.eg.db"}else
if (species == "drerio"){species.db <- "org.Dr.eg.db"}else
if (species == "ecoliK12"){species.db <- "org.EcK12.eg.db"}else
if (species == "ecoliSakai"){species.db <- "org.EcSakai.eg.db"}else
if (species == "ggallus"){species.db <- "org.Gg.eg.db"}else
if (species == "hsapiens"){species.db <- "org.Hs.eg.db"}else
if (species == "mmusculus"){species.db <- "org.Mm.eg.db"}else
if (species == "mmulatta"){species.db <- "org.Mmu.eg.db"}else
if (species == "pfalciparum"){species.db <- "org.Pf.plasmo.db"}else
if (species == "ptroglodytes"){species.db <- "org.Pt.eg.db"}else
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if (species == "rnorvegicus"){species.db <- "org.Rn.eg.db"}else
if (species == "scerevisiae"){species.db <- "org.Sc.sgd.db"}else
if (species == "scoelicolor"){species.db <- "org.Sco.eg.db"}else
if (species == "sscrofa"){species.db <- "org.Ss.eg.db"}else
if (species == "tgondii"){species.db <- "org.Tgondii.eg.db"}else
if (species == "xlaevis"){species.db <- "org.Xl.eg.db"}else
stop("organism must be one of the following:
agambiae, athaliana, btaurus, celegans, cfamiliaris
dmelanogaster, drerio, ecoliK12, ecoliSakai, ggallus
hsapiens, mmusculus, mmulatta, pfalciparum, ptrogldytes
rnorvegicus, scerevisiae, scoelicolor, sscrofa
tgondii, or xlaevis")
if (any(ID == c("entrez", "genbank", "alias", "ensemble", "symbol", "genename", "unigene"))){
gene.set.list <- annFUN.org(ontology, mapping = species.db, ID = ID)
return(gene.set.list)
}
}
}
interactiveGraph <- function(GO.Graph, color.nodes, interact = FALSE,
legend.pos = "bottomleft", print.legend = FALSE){
# Creates a graph showing all given gene sets and all parent gene sets
#
# Args:
# GO.Graph: A graphNEL object created by the function GOGraph. It contains
# all of the gene sets that will be in the graph.
# color.nodes: A character vector containing the gene sets that are of
# interest.
# interact: Indicates whether or not the graph should be
# interactive.
# legend.pos: Indicates what position the legend should be in.
# print.legend: Indicates whether or not a legend should be printed.
nodes <- buildNodeList(GO.Graph)
focusnode <- names(nodes) %in% color.nodes
names(focusnode) <- names(nodes)
nodefill <- ifelse(focusnode, "yellow", "white")
nAttrs <- list()
nAttrs$fillcolor <- nodefill
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nAttrs$label <- 1:length(names(nodes))
names(nAttrs$label) <- names(nodes)
pg <- plot(GO.Graph, nodeAttrs = nAttrs)
x <- getNodeXY(pg)$x
y <- getNodeXY(pg)$y
ordering <- sort.list(order(-y, x))
nAttrs$label <- ordering
names(nAttrs$label) <- names(nodes)
plot(GO.Graph, nodeAttrs = nAttrs)
Terms <- sapply(lookUp(names(nodes)[sort.list(ordering)], "GO", "TERM"), Term)
names(Terms) <- NULL
legend <- data.frame(Terms)
if(print.legend){
print(legend)
}
if(interact){
repeat {
p <- locator(n = 1)
if (is.null(p)) break()
pg <- plot(GO.Graph, nodeAttrs = nAttrs)
x <- getNodeXY(pg)$x
y <- getNodeXY(pg)$y
distance <- abs(p$x - x) + abs(p$y - y)
idx <- which.min(distance)
legend(legend.pos, legend=c(nAttrs$label[idx], names(focusnode)[idx],
Term(lookUp(names(focusnode)[idx],
"GO", "TERM")[[1]])), bg = "white")
}
}
}
go2GeneSet <- function(name, object){
# Creates a table showing the profile for a single gene set in each of the
# tested contrasts.
#
# Args:
# name: The name, or ID, of the desired gene set.
# object: A mvGST object containing a final results table.
#
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# Returns:
# A matrix with possible profiles as the row names and contrasts as the
# column names. Ones in the appropriate cells showing which profile the
# gene set fit for each contrast and zeroes elsewhere.
table <- object$results.table
single.table <- matrix(0, nrow = nrow(table), ncol = ncol(table), dimnames = dimnames(table))
observed <- profileCombine(object$ones.zeroes)
profs <- lapply(observed, function(x) x[object$group.names == name, ])
all.profs <- matrix(NA, nrow = nrow(table), ncol = ncol(observed[[1]]))
for (i in 1:nrow(table)){
raw.profile <- dimnames(table)[[1]][i]
temp <- substr(raw.profile, 3, nchar(raw.profile) - 1)
temp2 <- as.integer(strsplit(temp, ",")[[1]])
the.profile <- matrix(temp2, nrow = 1)
all.profs[i, ] <- the.profile
}
for (i in 1:ncol(single.table)){
row <- apply(t(profs[[i]] == t(all.profs)), MARGIN = 1, all)
single.table[row, i] <- 1
}
result <- list(results.table = single.table, ord.lev = object$ord.lev)
class(result) <- "mvGST"
return(single.table)
}
fillInList <- function(group, term, offspring, list.groups){
# Takes a gene sets in which genes are not associated
# with offspring terms from the GO ontology and includes all genes
# from offspring terms.
#
# Args:
# group: A character vector with the genes already associated
# with the set.
# term: The name of the gene set.
# offspring: A list showing the offspring sets of each gene set
# list.groups: A list showing all genes already associated with
# each gene set.
if (is.na(offspring[[term]][1])){
return(as.character(unlist(list.groups[term])))
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} else {
new.group <- unique(unlist(c(group, list.groups[offspring[[term]]])))
return(new.group)
}
}
